recombinant B-domain deleted human coagulation factor VIII Fc-von Willebrand factor-XTEN fusion protein

recombinant B-domain deleted human coagulation factor VIII Fc-von Willebrand factor-XTEN fusion protein
Trade Name
Orphan Indication Hemophilia A
USA Market Approval USA
USA Designation Date 2017-08-03 00:00:00
Sponsor Bioverativ Therapeutics, Inc.;225 2nd Avenue;Waltham, Massachusetts, 02451